Department of Colorectal Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, China.
Department of General Surgery, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Biomed Res Int. 2022 Jul 28;2022:3140070. doi: 10.1155/2022/3140070. eCollection 2022.
Most of colorectal cancer (CRC) cases are sporadic and develop along the adenoma-carcinoma sequence. Intestinal microbial dysbiosis is involved in the development of colorectal cancer. However, there are still no absolute markers predicting the progression from adenoma to carcinoma.
To investigate the characteristics of intestinal microbiota in colorectal adenoma and carcinoma patients and the correlations with clinical characteristics.
Fecal samples were collected from 154 colorectal carcinoma patients (CRC group), 20 colorectal adenoma patients (AD group), and 199 healthy controls (control group). The intestinal microbiota was investigated by 16S rRNA gene sequencing.
Compared to the healthy controls, microbial diversity was dramatically decreased in AD/CRC. At the genus level, significantly decreased with the order of control-AD-CRC ( < 0.05). , , , , , and were the key genera in the network of colorectal adenoma/carcinoma-associated bacteria. Combination of the top 10 most important species, including , , , bacterium feline oral taxon 001, , , bacterium LD2013, , bacterium 19gly4, and , showed the best performance in distinguishing AD patients from CRC (AUC = 85.54%, 95% CI: 78.83%-92.25%). The clinicopathologic features, including age, sex, tumor location, differentiation degree, and TNM stage, were identified to be closely linked to the intestinal microbiome in CRC.
Several intestinal bacteria changed along the adenoma-carcinoma sequence and might be the potential markers for the diagnosis and treatment of colorectal adenoma/carcinoma. Intestinal microbiota characteristics in CRC should account for the host factors.
大多数结直肠癌(CRC)病例是散发性的,沿着腺瘤-癌序列发展。肠道微生物失调与结直肠癌的发生有关。然而,目前仍然没有绝对的标志物可以预测从腺瘤到癌的进展。
研究结直肠腺瘤和癌患者肠道微生物群的特征及其与临床特征的相关性。
收集了 154 例结直肠癌患者(CRC 组)、20 例结直肠腺瘤患者(AD 组)和 199 例健康对照者(对照组)的粪便样本。采用 16S rRNA 基因测序方法研究肠道微生物群。
与健康对照组相比,AD/CRC 患者的微生物多样性显著降低。在属水平上,随着对照组-AD-CRC 的顺序, 显著减少( < 0.05)。 、 、 、 、 和 是结直肠腺瘤/癌相关细菌网络中的关键属。包括 、 、 、 、 、 、 、 、 和 在内的前 10 个最重要物种的组合,在区分 AD 患者和 CRC 患者方面表现最佳(AUC=85.54%,95%CI:78.83%-92.25%)。临床病理特征,包括年龄、性别、肿瘤位置、分化程度和 TNM 分期,被确定与 CRC 中的肠道微生物群密切相关。
一些肠道细菌沿着腺瘤-癌序列发生变化,可能是结直肠腺瘤/癌诊断和治疗的潜在标志物。CRC 中的肠道微生物群特征应考虑宿主因素。